Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumors
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Hiroki Hara Toshihiko Doi Takashi Kojima |
| Publication date | October 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |